The growing burden of non-alcoholic fatty liver disease on mortality

The growing burden of non-alcoholic fatty liver disease on mortality

Bibliographic Details
Main Authors:	Ju-Yeon Cho, Won Sohn
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2023-04-01
Series:	Clinical and Molecular Hepatology
Subjects:	nonalcoholic fatty liver disease global burden of disease mortality
Online Access:	http://e-cmh.org/upload/pdf/cmh-2023-0084.pdf

Similar Items

Global health burden of cirrhosis and other chronic liver diseases (CLDs) due to non-alcoholic fatty liver disease (NAFLD): A systematic analysis for the global burden of disease study 2019
by: Jie Li, et al.
Published: (2023-01-01)

Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990–2019: a systematic analysis for the GBD 2019
by: Juan Pang, et al.
Published: (2022-08-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study
by: Kil Woo Lee, et al.
Published: (2015-12-01)

Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease
by: Joon Ho Moon, et al.
Published: (2022-05-01)

Recent research trends and updates on nonalcoholic fatty liver disease
by: Jeong-Ju Yoo, et al.
Published: (2019-03-01)

Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index at Diagnosis Is Associated with All-Cause Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Minsuk Cho, et al.
Published: (2024-02-01)

Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis
by: Wasit Wongtrakul, et al.
Published: (2024-05-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
by: Ji-Won Park, et al.
Published: (2023-04-01)

Low ankle–brachial index is associated with higher cardiovascular mortality in individuals with nonalcoholic fatty liver disease
by: Guang Xiong, et al.
Published: (2024-05-01)

Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact
by: David Højland Ipsen, et al.
Published: (2021-01-01)

The association between nonalcoholic fatty liver disease and cardiovascular disease: A window of opportunity
by: Narendra Singh Choudhary, et al.
Published: (2021-01-01)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
by: Margaret LP Teng, et al.
Published: (2023-04-01)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
by: Ho Soo Chun, et al.
Published: (2023-04-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

Non-alcoholic fatty liver disease and cognitive impairment
by: Elena V. Onuchina, et al.
Published: (2024-12-01)

Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)

Electrocardiographic and echocardiographic changes in nonalcoholic fatty liver disease
by: Ahmed S Elsawaby, et al.
Published: (2019-01-01)

Functional-morphological changes in non-alcoholic fatty liver disease after bariatric operations
by: Iu. I. Sedletskii, et al.
Published: (2019-02-01)

Serum Calcium and Phosphorus Concentration in Egyptian Patients with Non-Alcoholic Fatty liver disease
by: Mohammed F. Mohammed, et al.
Published: (2023-07-01)

Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030
by: Khalid Alswat, et al.
Published: (2018-01-01)

Non-alcoholic Fatty Liver Disease in Children
by: Abolfazl Iranikhah, et al.
Published: (2018-10-01)

The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
by: Francesco Massimo Perla, et al.
Published: (2017-06-01)

Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
by: Eugene Han, et al.
Published: (2022-09-01)

Association of insulin resistance and non-alcoholic fatty liver disease
by: Ekaterina E. Mishina, et al.
Published: (2021-01-01)

The effect of symbiotic supplementation on liver enzymes, c-reactive protein and ultrasound findings in patients with non-alcoholic fatty liver disease: A clinical trial
by: Atefe Asgharian, et al.
Published: (2016-01-01)

Elastography—A Bona Fide Non-Invasive Method for Assessing Non-Alcoholic Fatty Liver Disease in Children
by: Cristina Oana Mărginean, et al.
Published: (2021-04-01)

Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011–2016)
by: Debashis Reja, et al.
Published: (2020-07-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

The burden of liver cirrhosis in mortality: Results from the global burden of disease study
by: Fei Ye, et al.
Published: (2022-08-01)

Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
by: Jihyun An, et al.
Published: (2023-02-01)

Multi-system diseases and death trajectory of metabolic dysfunction-associated fatty liver disease: findings from the UK Biobank
by: Yu Jia, et al.
Published: (2023-10-01)

The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
by: Hassan Pakravan, et al.
Published: (2017-01-01)

Non-invasive evaluation of liver stiffness in nonalcoholic fatty liver disease: supersonic shear imaging, FibroScan or ARFI?
by: Coskun Ozturker, et al.
Published: (2016-12-01)

Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2022-04-01)

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Byoung Kuk Jang
Published: (2012-12-01)

A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
by: V.N. Santos, et al.
Published: (2003-06-01)